Alternative splicing of human metabotropic glutamate receptor 3
- 26 January 2006
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 96 (4), 1139-1148
- https://doi.org/10.1111/j.1471-4159.2005.03609.x
Abstract
The metabotropic glutamate receptor 3 (GRM3, mGluR3) is important in regulating synaptic glutamate. Here, we report the existence of three splice variants of GRM3 in human brain arising from exon skipping events. The transcripts are expressed in prefrontal cortex, hippocampus and cerebellum, and in B lymphoblasts. We found no evidence for alternative splicing of GRM2. The most abundant GRM3 variant lacks exon 4 (GRM3Delta4). In silico translation analysis of GRM3Delta4 predicts a truncated protein with a conserved extracellular ligand binding domain, absence of a seven-transmembrane domain, and a unique 96-amino acid C-terminus. When expressed in rat hippocampal neurons, GRM3Delta4 is translated into a 60 kDa protein. Immunostaining and cell fractionation data indicate that the truncated protein is primarily membrane-associated. An antibody developed against the GRM3Delta4 C-terminus detects a protein of approximately 60 kDa in human brain lysates and in B lymphoblasts, suggesting translation of GRM3Delta4 in vivo. The existence of the GRM3Delta4 isoform is relevant in the light of the reported association of non-coding single nucleotide polymorphisms (SNPs) in GRM3 with schizophrenia, and with the potential of GRM3 as a therapeutic target for several neuropsychiatric disordersKeywords
This publication has 35 references indexed in Scilit:
- A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese populationSchizophrenia Research, 2005
- Expression of a truncated secreted form of the mGluR3 subtype of metabotropic glutamate receptorBiochemical and Biophysical Research Communications, 2004
- Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene ( GRM3 ) with schizophreniaPsychiatric Genetics, 2003
- LY354740, an mGlu2/3 Receptor Agonist as a Novel Approach to Treat Anxiety/StressStress, 2003
- The Effect of Groups II and III Metabotropic Glutamate Receptor Activation on Neuronal Injury in a Rodent Model of Traumatic Brain InjuryNeurosurgery, 2001
- Cryptic Dimer Interface and Domain Organization of the Extracellular Region of Metabotropic Glutamate Receptor Subtype 1Journal of Biological Chemistry, 2000
- Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S‐100β protein from cultured astrocytesGlia, 1999
- Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in RatsScience, 1998
- A metabotropic glutamate receptor agonist DCG-IV suppresses synaptic transmission at mossy fiber pathway of the guinea pig hippocampusNeuroscience Letters, 1996
- The type II ‘decoy’ receptor: A novel regulatory pathway for interleukin 1Immunology Today, 1994